SHORT-TERM OUTCOME OF ESOPHAGECTOMY AFTER NEOADJUVANT CHEMORADIATION FOR LOCALLY ADVANCED ESOPHAGEAL CANCER

An Nguyễn Thị Thoại, Thắng Đặng Huy Quốc, Tiến Quan Anh, Sơn Đặng Ngọc, Phong Lềnh Thanh, Vinh Nguyễn Quốc, Cường Phạm Hùng

Main Article Content

Abstract

Introduction: Esophageal cancer is a highly aggressive malignancy with a rising global incidence and poor prognosis. Neoadjuvant chemoradiotherapy (nCRT) in conjunction with radical esophagectomy has demonstrated superior outcomes compared to primary surgery in the treatment of locally advanced esophageal cancer. However, most existing studies have been conducted in Western populations, while data from Asian countri es, particularly Vietnam, remain limited. Aim: This study aims to evaluate the safety and viability of implementing radical esophagectomy surgery following nCRT in patients with locally advanced esophageal cancer. Methodology: A retrospective descriptive study was conducted on 46 patients diagnosed with locally advanced esophageal cancer who underwent nCRT followed by McKeown esophagectomy with lymph node dissection at the Department of Abdominal and Thoracic Surgery, Oncology Hospital, Vietnam, between December 2020 and June 2024. Result: Baseline characteristics indicated that all participants were male, with 71.8% identified as smokers and 45.6% having a history of alcohol consumption. The median interval between completion of nCRT and surgery was 65 days. The median operative duration was 320 minutes, with a median blood loss of 180 mL. Perioperative mortality was 2,2% and postoperative pulmonary complications were 30,4%. The median postoperative hospital stay was 14 days. All patients achieved R0 resection margins, with 47,8% demonstrating a pathological complete response (pCR). Conclusion: The study’s outcomes emphasize the safety and feasibility of employing McKeown esophagectomy following nCRT in Vietnamese patients, with an acceptable complication rate and favorable surgical outcomes.

Article Details

References

1. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. May-Jun 2024;74(3):229-263. doi:10.3322/caac.21834
2. Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. Jan 2012;19(1):68-74. doi:10.1245/s10434-011-2049-9
3. van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. May 31 2012;366(22):2074-84. doi:10.1056/ NEJMoa1112088
4. Yang H, Liu H, Chen Y, et al. Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial. J Clin Oncol. Sep 20 2018;36(27):2796-2803. doi:10.1200/jco.2018.79.1483
5. Nguyễn Thị Minh Huệ, Nguyễn Văn Hải, Lê Tuấn Anh, et al. Biến chứng điều trị của hóa trị tân hỗ trợ phác đồ Docetaxel-cisplatin-capecitabine/5-fluorouracil (DCX/DCF). Tạp chí Y Học TP Hồ Chí Minh. 2022;Tập 26(Số 1)
6. Isono K, Ochiai T, Koide Y. Indications for extended three-field lymphadenectomy for esophageal cancer. Diseases of the Esophagus. 1994;7(3):147-150. doi:10.1093/dote/7.3.147
7. Nguyễn Đức Duy, Phạm Văn Bình, Trần Đại Mạnh, et al. Kết quả sớm phẫu thuật cắt thực quản xâm lấn tối thiểu trên nhóm bệnh nhân ung thư biểu mô vảy thực quản hóa xạ trị tiền phẫu tại bệnh viện K. Tạp chí Y Học Việt Nam. 2024;Tháng 2(Số 1B)
8. Metzger R, Bollschweiler E, Vallböhmer D, Maish M, DeMeester TR, Hölscher AH. High volume centers for esophagectomy: what is the number needed to achieve low postoperative mortality? Dis Esophagus. 2004;17(4):310-4. doi:10.1111/j.1442-2050.2004.00431.x
9. Hùng TM, Kiên NT, Kiên TT. Kết quả phẫu thuật nội soi ngực-bụng cắt thực quản điều trị ung thư thực quản tại bệnh viện Bạch Mai. Tạp chí Y học Việt Nam. 2024;537(1)
10. Lợi NĐ. Đánh giá hiệu quả phác đồ hóa xạ trị đồng thời và một số yếu tố tiên lượng ung thư biểu mô thực quản giai đoạn III-IV tại Bệnh viện K. Luận án tiến sỹ y học, Đại học Y Hà Nội. 2015;